Equity · Healthcare
PFE
NYSEPfizer (PFE)
The line runs 25.07 USD on 3 August through 30.50 USD on 30 October, on a scale from 24 to 32. Days the market did not trade hold the previous close, flat.
- Market cap
- 173.8B USD
- P/E (TTM)
- 40.1
- Revenue, year to Dec 2025
- 62.6B USD
- EPS, diluted, year to Dec 2025
- 1.36 USD
- 52-week range
- 23.77 USD – 30.50 USD
- Avg volume
- 1.8M
- Mentions, 30 days
- 69
- Net sentiment
- +0.11
as of Oct 30, 2026
Have Pfizer (PFE) insiders bought or sold shares recently?
In the 90 days to 1 Nov 2026, Pfizer insiders reported 1 open-market sale and 3 purchases (SEC Form 4).
Form 4, 90 days to 1 Nov 2026, newest reported trade 12 Aug 2026
Buys 3Sells 1Net bought $2.88MOther filings 0
| Reported | Insider | Type | Shares | Value |
|---|---|---|---|---|
| 12 Aug 2026 | BOURLA ALBERTChairman & CEO | Buy | 38,000 | 1.0M USD |
| 05 Aug 2026 | DAMICO JENNIFER B.SVP & Controller | Sell | 3,278 | 83K USD |
| 05 Aug 2026 | BLAYLOCK RONALD EDirector | Buy | 39,231 | 999K USD |
| 05 Aug 2026 | Buckley Mortimer JDirector | Buy | 37,632 | 960K USD |
| Bought | 3 open-market purchases | 114,863 | $2.96M | |
| Sold | 1 open-market sale | 3,278 | $83K |
Which funds hold Pfizer (PFE)?
12 of the 45 institutional funds we track reported a Pfizer position for the quarter ended 30 Jun 2026 — a combined 3.5B USD; the latest of those filings landed 02 Sep 2026.
| Fund | Position | Shares | Value | Shares q/q |
|---|---|---|---|---|
| Fisher Asset Management | Held (±25%) | 109,067,291 | 2.6B USD | +3.9% |
| AQR Capital Management | Added | 18,557,891 | 445.0M USD | +56.2% |
| Citadel Advisors | Held (±25%) | 6,191,186 | 149.1M USD | −15.9% |
| D. E. Shaw & Co. | Trimmed | 5,414,297 | 130.4M USD | −56.6% |
| Man Group | Held (±25%) | 912,739 | 22.0M USD | −7.4% |
| Balyasny Asset Management | Trimmed | 857,605 | 20.7M USD | −91.8% |
| Marshall Wace | Trimmed | 802,396 | 19.3M USD | −95.0% |
| Tudor Investment Corp | New position | 697,000 | 16.8M USD | |
| GAMCO Investors | Held (±25%) | 571,286 | 13.8M USD | −3.1% |
| Millennium Management | Added | 556,133 | 13.4M USD | +477.1% |
Showing the 10 largest of 12 reported positions. The figures above count all of them.
Have members of Congress traded Pfizer (PFE)?
The most recent congressional trade disclosed in Pfizer is a sale by Gilbert Ray Cisneros, Jr. (house, CA), dated 13 Mar 2026.
STOCK Act disclosures
| Traded | Member | Type | Amount | Filed after |
|---|---|---|---|---|
| 13 Mar 2026 | Gilbert Ray Cisneros, Jr.house · Democrat–CA | Sale | 1K USD–15K USD | 25 days |
| 10 Feb 2026 | Gilbert Ray Cisneros, Jr.house · Democrat–CA | Purchase | 1K USD–15K USD | 27 days |
| 31 Dec 2025 | J. French Hillhouse · Republican–AR | Sale | 100K USD–250K USD | 23 days |
| 18 Nov 2025 | Gilbert Ray Cisneros, Jr.house · Democrat–CA | Purchase | 1K USD–15K USD | 27 days |
| 05 Aug 2025 | Gilbert Ray Cisneros, Jr.house · Democrat–CA | Sale | 1K USD–15K USD | 38 days |
| 04 Aug 2025 | Lisa C. McClainhouse · Republican–MI | Sale | 1K USD–15K USD | 39 days |
| 16 Jul 2025 | Lisa C. McClainhouse · Republican–MI | Purchase | 1K USD–15K USD | 28 days |
| 17 Jun 2025 | Julia Letlowhouse · Republican–LA | Purchase | 1K USD–15K USD | 210 days |
Pfizer (PFE) US federal contracts
The most recent US federal contract to Pfizer (PFE) is 543K USD from the Office of Assistant Secretary for Preparedness and Response, signed 15 May 2026.
USAspending.gov
Fiscal 2025 1.4M USDFiscal 2023 1.9B USD
| Signed | Agency | Contract | Committed |
|---|---|---|---|
| 15 May 2026 | Office of Assistant Secretary for Preparedness and ResponseDepartment of Health and Human Services | STERILE WATER FOR INJECTION, 20MLDRUGS AND BIOLOGICALS · 75A50326F63004 | 543K USD |
| 26 Aug 2025 | Defense Logistics AgencyDepartment of Defense | 8511599130!OTHER MEDICALDRUGS AND BIOLOGICALS · SPE2D025F0634 | 787K USD |
| 13 Feb 2025 | Office of Assistant Secretary for Preparedness and ResponseDepartment of Health and Human Services | STERILE WATER FOR INJECTION 20MLDRUGS AND BIOLOGICALS · 75A50325F63003 | 1.2M USD |
| 30 Sep 2024 | Office of Assistant Secretary for Preparedness and ResponseDepartment of Health and Human Services | THE PURPOSE OF THIS DELIVERY ORDER IS TO PROCURE PHARMACEUTICALS TO REPLENISH EXPIRED PRODUCT.DRUGS AND BIOLOGICALS · 75A50324F80014 | 2.2M USD |
| 25 Sep 2024 | Department of Veterans Affairs | CIPROFLOXACINDRUGS AND BIOLOGICALS · 36C77024P0393 | 243K USD |
| 26 Aug 2024 | Defense Logistics AgencyDepartment of Defense | 8510849631!OTHER MEDICALDRUGS AND BIOLOGICALS · SPE2D024F0552 | 925K USD |
| 02 Nov 2023 | Centers for Disease Control and PreventionDepartment of Health and Human Services | COVID-19 (COMIRNATY) VACCINE PURCHASEDRUGS AND BIOLOGICALS · 75D30124F18352 | 112K USD |
| 04 Oct 2023 | Department of Veterans Affairs | COVID VACCINEDRUGS AND BIOLOGICALS · 36C25024F0047 | 215K USD |
| 30 Sep 2023 | Department of State | AUTOINJECTORS AND TRAINERSDRUGS AND BIOLOGICALS · 19AQMM23F3176 · MERIDIAN MEDICAL TECHNOLOGIES, LLC | 18.0M USD |
| 22 Sep 2023 | Office of Assistant Secretary for Preparedness and ResponseDepartment of Health and Human Services | PURCHASE DUODOTE SINGLE DOSE AUTOINJECTORS - EMERGENCY PROCUREMENT.CHEMICAL AND PHARMACEUTICAL PRODUCTS MANUFACTURING MACHINERY · 75A50323C00027 · MERIDIAN MEDICAL TECHNOLOGIES, LLC | 9.9M USD |
Newest first: 10 of 18 contracts. Contracts of US$100,000 or more signed since April 2022; the amount is what the government has committed so far, which grows when options are exercised. Defense Department contracts are published about 90 days after signing, so the latest year is still filling in.
What has been filed or recorded for Pfizer (PFE)?
The filings we hold for Pfizer, newest first: 13 fails-to-deliver days, 6 quarterly earnings reports, 2 annual reports and 5 reported financial figures, the latest dated 13 Oct 2026. No next earnings date is announced in SEC filings yet.
| And | ||||
|---|---|---|---|---|
| 13 Oct 2026 | Fails to deliver | Shares failed to deliver | 2,148 shares | 61K USD notional · <0.001% of shares out |
| 09 Oct 2026 | Fails to deliver | Shares failed to deliver | 680 shares | 19K USD notional · <0.001% of shares out |
| 08 Oct 2026 | Fails to deliver | Shares failed to deliver | 127,594 shares | 3.6M USD notional · 0.002% of shares out |
| 07 Oct 2026 | Fails to deliver | Shares failed to deliver | 777 shares | 21K USD notional · <0.001% of shares out |
| 06 Oct 2026 | Fails to deliver | Shares failed to deliver | 7,821 shares | 214K USD notional · <0.001% of shares out |
| 05 Oct 2026 | Fails to deliver | Shares failed to deliver | 1,000 shares | 28K USD notional · <0.001% of shares out |
| 01 Oct 2026 | Fails to deliver | Shares failed to deliver | 115 shares | 3K USD notional · <0.001% of shares out |
| 28 Sep 2026 | Fails to deliver | Shares failed to deliver | 60,271 shares | 1.7M USD notional · 0.001% of shares out |
| 24 Sep 2026 | Fails to deliver | Shares failed to deliver | 4,222 shares | 119K USD notional · <0.001% of shares out |
| 22 Sep 2026 | Fails to deliver | Shares failed to deliver | 10,319 shares | 286K USD notional · <0.001% of shares out |
| 21 Sep 2026 | Fails to deliver | Shares failed to deliver | 77,945 shares | 2.2M USD notional · 0.001% of shares out |
| 18 Sep 2026 | Fails to deliver | Shares failed to deliver | 37,787 shares | 1.0M USD notional · 0.001% of shares out |
| 17 Sep 2026 | Fails to deliver | Shares failed to deliver | 500 shares | 14K USD notional · <0.001% of shares out |
| 28 Jun 2026 | Quarterly earnings | Q2 2026 reported | EPS −0.04 USD | Revenue $15.03B |
| 28 Jun 2026 | Financials | Total assets | 201.1B USD | at period end |
| 28 Jun 2026 | Financials | Total equity | 85.2B USD | at period end |
| 29 Mar 2026 | Quarterly earnings | Q1 2026 reported | EPS 0.47 USD | Revenue $14.45B |
| 31 Dec 2025 | Annual report | FY 2025 reported | EPS 1.36 USD | Revenue $62.58B |
| 31 Dec 2025 | Financials | Revenue | 62.6B USD | fiscal year |
| 31 Dec 2025 | Financials | Net income | 7.8B USD | fiscal year |
| 31 Dec 2025 | Financials | Diluted EPS | 1.36 USD | fiscal year |
| 28 Sep 2025 | Quarterly earnings | Q3 2025 reported | EPS 0.62 USD | Revenue $16.65B |
| 29 Jun 2025 | Quarterly earnings | Q2 2025 reported | EPS 0.51 USD | Revenue $14.65B |
| 30 Mar 2025 | Quarterly earnings | Q1 2025 reported | EPS 0.52 USD | Revenue $13.72B |
| 31 Dec 2024 | Annual report | FY 2024 reported | EPS 1.41 USD | Revenue $63.63B |
| 29 Sep 2024 | Quarterly earnings | Q3 2024 reported | EPS 0.78 USD | Revenue $17.70B |
What is Reddit saying about Pfizer (PFE)?
Reddit mentioned PFE 69 times in the 30 days to 31 October 2026, across 7 of the communities we track. All of them were scored for sentiment: 67% read bullish, 9% bearish and 24% neither. Reddit data updated 31 October 2026.
30-day window, Method
Mentions, 30 days 69Bullish 67%Bearish 9%Communities 7Against the market +13 points
How do Reddit mentions of Pfizer (PFE) compare with its price?
Share ↗
Is the Reddit crowd more bullish on Pfizer than on the market?
PFE reads 50% bullish, 3 points below the market (53%). Over 90 days the gap has run from -39 to +25 points.
- PFE
- 50%
- bullish, 31 Oct
- Market
- 53%
- bullish, all Reddit, 31 Oct
- Gap
- −3 pts
- PFE against market
Where Pfizer (PFE) is discussed
30 days
| Community | Share | Mentions | Net sentiment |
|---|---|---|---|
| r/wallstreetbets | 72% | 50 | +0.12 |
| r/options | 9% | 6 | +0.05 |
| r/stocks | 7% | 5 | +0.14 |
| r/investing | 6% | 4 | +0.14 |
| r/ausfinance | 3% | 2 | +0.08 |
| r/cryptocurrency | 1% | 1 | −0.03 |
| r/asx_bets | 1% | 1 | +0.01 |
Moves with Pfizer (PFE)
Tickers whose daily Reddit volume rose and fell with Pfizer (PFE)'s. Co-discussion, not price.
RKLB +0.77IT +0.76OKTA +0.75CORE CPI +0.74ASML +0.74CMC +0.73
How closely daily Reddit mention counts rose and fell together over the last 30 days (31 daily observations), Method
Pfizer (PFE): frequently asked questions
What did Pfizer shares close at?
Pfizer closed at 30.50 USD on 30 Oct 2026, up 1.84% on the close before. That is the end-of-day price from Finazon, not a live quote.
What is Pfizer’s market cap?
Pfizer is worth 173.8B USD by market value as of 30 Oct 2026, which is the share price times the shares on issue from its SEC filings.
What is Pfizer’s P/E ratio?
Pfizer has a price-to-earnings ratio of 40.1, as of 30 Oct 2026: the share price divided by what the company earned per share over the last four reported quarters. A higher number means the market pays more for each dollar of earnings.
What is Pfizer’s revenue?
Pfizer reported revenue of 62.6B USD for the year ended 31 Dec 2025, as filed with the SEC. See Filings
Have Pfizer insiders bought or sold shares recently?
In the 90 days to 1 Nov 2026, Pfizer insiders reported 1 open-market sale and 3 purchases (SEC Form 4). See Insiders
Which funds own Pfizer?
12 of the 45 funds we track reported a Pfizer position for the quarter ended 30 Jun 2026, per their SEC Form 13F filings. The largest reported positions were Fisher Asset Management, AQR Capital Management and Citadel Advisors. See Funds
Have members of Congress traded Pfizer?
Yes. 78 trades in Pfizer appear in the congressional disclosures we hold; the latest is a sale by Gilbert Ray Cisneros, Jr. (House, CA) dated 13 Mar 2026, filed 7 Apr 2026. Amounts are disclosed as ranges, and a filing can follow the trade by up to 45 days. See Congress
When did Pfizer last report earnings?
Pfizer last reported earnings on 28 Jun 2026 for Q2 2026, with EPS of −0.04 USD; no next date is announced in SEC filings yet. See Filings
What is Reddit saying about Pfizer?
Pfizer was mentioned 6 times in the last 7 days across the finance subreddits we track, and 69 times over the trailing 30 days. Of the 69 mentions scored for sentiment, 67% read bullish and 9% bearish. That is a social signal, not investment advice. See Reddit
Answers are generated from the live figures on this page — Reddit crowd data, SEC filings and open company records — and update as the data does.
References
- Finazonprior-day close, indicative (IEX-derived, not the official close), some closes dollar-rounded at the source
- TradingViewthe price chart widget, drawn by TradingView from their own data
- RedditReddit ingest across the tracked finance subreddits
- SEC EDGARForm 4 filings (insider transactions)
- SEC EDGAR13F filings
- House disclosuresU.S. House of Representatives financial disclosures
- USAspendingUSAspending.gov (U.S. Department of the Treasury), federal prime contract awards
- SECSEC fails-to-deliver (CNS) data
- SEC EDGARXBRL company facts, latest period ended 28 Jun 2026
- SEC EDGARreported earnings figures and scheduled report dates
- SEC EDGARValuation computed from SEC EDGAR filings